In addition, isunakinra limited NF-κΒ activation in KrasMUT cancer cells in vivo, a phenomenon we previously showed to be fueled by myeloid IL-1β, as well as their ability for lethal MPE induction (Figure 6B–D). The gene discussed is IL1B; the disease is cancer.